NCT01548209View on ClinicalTrials.gov

Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

August 31, 2012

Conditions
Breast Cancer
Interventions
DRUG

Dexmedetomidine

A single dose dexmedetomidine 0.5 mcg/kg IV. 30 min before end of the surgery

DRUG

Placebo

Placebo 0.5 mcg/kg iv. 30 min before end of the surgery

Trial Locations (1)

120-752

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 250 Seungsan-no, Seodaemun-gu, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01548209 - Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery | Biotech Hunter | Biotech Hunter